A retrospective case-control study of reasons for referral, main distresses, and goals of care among HIV/AIDS and cancer patients in palliative care

一项回顾性病例对照研究,探讨了接受姑息治疗的艾滋病病毒感染者/艾滋病患者和癌症患者的转诊原因、主要困扰和治疗目标。

阅读:3

Abstract

As many as 80% of patients receiving palliative care at Hospice Africa Uganda have cancer and/or HIV/AIDS. Given that cancer and HIV/AIDS have different trajectories since antiretroviral therapy (ART) became widely available, these two patients groups may differ in their care needs. This study's main objective was to identify, summarise and compare the reasons for referral, main distresses, and goals of care among cancer and HIV/AIDS patients in palliative care. A cross-sectional study employing a retrospective design was conducted on 100 consecutively sampled charts consisting of 50 cancer and 50 HIV/AIDS patients. Data were extracted using a researcher-developed structured checklist. Data were entered and analysed in STATA, version 17 using descriptive statistics and Chi-Square (χ(2)) test. A P-value less than 0.05 was considered statistically significant. The primary reason for referral to palliative care was pain and symptom control at 22 (44%) and 36(72%) among cancer patients and HIV/AIDS patients respectively (χ(2) = 8.046, P = 0.005). The most prevalent main distress in both groups was unrelieved pain at 23(46%) in the cancer group versus 24(48%) in the HIV/AIDS group (χ(2) = 0.0401, P = 0.841). The most common goal of care was pain and symptom control at 33(66%) and 29(58%) among cancer patients and HIV/AIDS patients respectively (χ(2) = 0.6791, P = 0.41). The study findings showed that pain is the most prevalent symptom and the main cause of distress in HIV/AIDs and cancer patients in palliative care. Clinicians need to prioritize pain and symptoms assessment and management in order to optimise quality of life for patients and their families.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。